PHARMACOKINETIC AND PHARMACODYNAMIC MODELING OF LY2951742, A CALCITONIN GENE RELATED PEPTIDE ANTIBODY, IN MIGRAINE PATIENTS

被引：0
|
作者：
Kielbasa, W. [1 ]
Quinlan, T. [1 ]
Bell, R. [1 ]
Miller, B. [2 ]
Skljarevski, V. [3 ]
机构：
[1] Eli Lilly & Co, Global PKPD, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Neurosci Tailoring, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Med, Indianapolis, IN 46285 USA
来源：
CEPHALALGIA | 2016年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EHMTC-0112
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [21] Sustained Response Outcomes from a Phase 2a, Randomized, Double-blind, Placebo-controlled Study of LY2951742, a Monoclonal Antibody to Calcitonin Generelated Peptide, for the Prevention of Migraine: A Post-hoc Analysis
    Dodick, D. W.
    Goadsby, P. J.
    Ferguson, M.
    Oakes, T.
    Tanaka, Y.
    Ni, X.
    Zhang, Q.
    Due, M.
    Skljarevski, V
    Martinez, J.
    HEADACHE, 2015, 55 : 177 - 177
  • [22] Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention
    Morgan, Kelsey Woods
    Joyner, Kayla Rena
    SAGE OPEN MEDICINE, 2021, 9
  • [23] Nutrition and Calcitonin Gene Related Peptide (CGRP) in Migraine
    Fila, Michal
    Chojnacki, Jan
    Sobczuk, Piotr
    Chojnacki, Cezary
    Blasiak, Janusz
    NUTRIENTS, 2023, 15 (02)
  • [24] Pharmacokinetics, Pharmacodynamics and Safety of Galcanezumab, a Calcitonin Gene-Related Peptide Monoclonal Antibody, in Pediatric Patients with Migraine
    Kielbasa, W.
    Quinlan, T.
    Kabbouche, M.
    McVige, J.
    Li, L.
    Detke, H.
    Das, S.
    Camporeale, A.
    Upadhyaya, H.
    HEADACHE, 2023, 63 : 152 - 153
  • [25] Calcitonin gene-related peptide (CGRP) in migraine
    Olesen, Jes
    CEPHALALGIA, 2011, 31 (04) : 510 - 510
  • [26] Calcitonin gene-related peptide (CGRP) and migraine
    Durham, PL
    HEADACHE, 2006, 46 : S3 - S8
  • [27] Efficacy and safety of LY2951742 in a randomized, double-blind, placebo-controlled, dose-ranging study in patients with migraine
    Oakes, T.
    Zhang, Q.
    Ferguson, M.
    Skljarevski, V
    Martinez, J. M.
    Johnson, K. W.
    Schacht, A. L.
    Due, M. R.
    Goadsby, P.
    Dodick, D. W.
    HEADACHE, 2016, 56 : 68 - 68
  • [28] EFFICACY AND SAFETY OF LY2951742 IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY IN PATIENTS WITH MIGRAINE
    Skljarevski, V.
    Oakes, T.
    Ferguson, M.
    Zhang, Q.
    Martinez, J.
    Johnson, K.
    Schacht, A.
    Due, M.
    Goadsby, P.
    Dodick, D.
    CEPHALALGIA, 2016, 36 : 42 - 42
  • [29] Serum Calcitonin Gene-Related Peptide Is Elevated in Patients With Migraine and Ophthalmoplegia
    Takkar, Aastha
    Kumar, K. V. Anil
    Katoch, Deeksha
    Singh, Paramjeet
    Minz, Ranjana
    Anand, Shashi
    Kathirvel, Soundappan
    Ravishankar, K.
    Lal, Vivek
    Caplan, Louis R.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2023, 43 (03) : 399 - 405
  • [30] Analysis of the relationship between efficacious clinical doses for inhibition of capsaicin-induced dermal blood flow and migraine prevention for the CGRP neutralizing antibody LY2951742
    Collins, E. C.
    Zhang, Q.
    Polzer, J.
    Kielbasa, W.
    Raddad, E.
    Johnson, K. W.
    HEADACHE, 2016, 56 : 8 - 8
12345